B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)

Detalles Bibliográficos
Autores principales: Petersen, D L, Krejsgaard, T, Berthelsen, J, Fredholm, S, Willerslev-Olsen, A, Sibbesen, N A, Bonefeld, C M, Andersen, M H, Francavilla, C, Olsen, J V, Hu, T, Zhang, M, Wasik, M A, Geisler, C, Woetmann, A, Odum, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190403/
https://www.ncbi.nlm.nih.gov/pubmed/24919804
http://dx.doi.org/10.1038/leu.2014.192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190403/
https://www.ncbi.nlm.nih.gov/pubmed/24919804
http://dx.doi.org/10.1038/leu.2014.192

Ejemplares similares